Renal Transplantation
📧 Sign up to get email alerts when something new happens for Renal Transplantation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-07-30Clinical Trial Update: Comparative Bioavailability of Myfenax® and CellCept® in Kidney Transplant Patients [Phase 4]
Phase 4 trial comparing bioavailability of mycophenolate mofetil products in stable renal transplant recipients; study terminated with resul…
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: A Study of Mycophenolate Mofetil and Cyclosporin, Without Concomitant Corticosteroids, After a First Renal Transplant [Phase 4]
Phase 4 study evaluating mycophenolate mofetil with cyclosporine without corticosteroids after a first renal transplant has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-26Clinical Trial Update: Campath, Rituximab, and Myfortic With Short-Course Calcineurin Inhibitor Therapy in Renal Transplanation [NA]
A renal transplant trial evaluating Campath (alemtuzumab), rituximab, and Myfortic with short-course calcineurin inhibitor therapy was termi…
-
CLINICAL_TRIALS trial_result · 2012-06-22Clinical Trial Update: Comparisone of Iminoral Versus Neoral in Prevention of Acute Rejection in Renal Transplantation [Phase 4]
Phase 4 clinical trial comparing Iminoral versus Neoral for prevention of acute rejection in renal transplantation has been completed.
-
CLINICAL_TRIALS trial_result · 2012-06-07Clinical Trial Update: Lowering Total Immunosuppressive Load in Renal Transplant Recipients More Than 12 Months Posttransplant [Phase 4]
A Phase 4 clinical trial from the University of Oslo School of Pharmacy evaluating strategies to lower total immunosuppressive load in renal…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-05-30Clinical Trial Update: Renal Tubular Acidosis in Incident Renal Transplant Recipients
Clinical trial update about renal tubular acidosis in incident renal transplant recipients; the current status of the study is unknown.
-
CLINICAL_TRIALS trial_result · 2012-02-29Clinical Trial Update: Study To Evaluate Pharmacokinetics Of Sirolimus In Stable Renal Transplant Recipients [Phase 1]
Phase 1 trial update reporting pharmacokinetics of sirolimus in stable renal transplant recipients; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2011-11-02Clinical Trial Update: Long Term Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients [Phase 3]
Phase 3 trial evaluating long-term efficacy and safety of fingolimod (FTY720) in de novo adult renal transplant recipients has completed.
-
CLINICAL_TRIALS trial_result · 2011-11-02Clinical Trial Update: Study to Evaluate the Combination of Enteric-coated Mycophenolate Sodium (EC-MPS), Basiliximab, and C2-monitored Cyclosporine in de Novo Renal Transplant Recipients at Potential High Risk of Delayed Graft Function (DGF) [Phase 4]
A Phase 4 study evaluating a triple immunosuppressive regimen (EC-MPS, basiliximab, and C2-monitored cyclosporine) in de novo renal transpla…
-
CLINICAL_TRIALS trial_result · 2011-11-02Clinical Trial Update: Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients [Phase 2]
Phase 2 trial evaluating the efficacy and safety of FTY720 (fingolimod) in de novo adult renal transplant recipients has completed.
-
CLINICAL_TRIALS trial_result · 2011-11-02Clinical Trial Update: Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A0107 [Phase 3]
A Phase 3 follow-up study evaluating the safety of enteric-coated mycophenolate sodium in renal transplant recipients who completed the prio…
-
CLINICAL_TRIALS trial_result · 2011-11-02Clinical Trial Update: This is a 2-year Follow-up Study to Evaluate the Long-term Effects in Patients Who Completed the Study CRAD001A2307. [Phase 3]
Two-year follow-up from Phase 3 trial CRAD001A2307 evaluating long-term effects in renal transplant recipients who completed the study.
-
CLINICAL_TRIALS trial_result · 2011-11-02Clinical Trial Update: This is a Two-year Follow-up Study to Evaluate the Long-term Safety, Tolerability and Efficacy of 2 Different Doses of Everolimus [Phase 3]
This ClinicalTrials.gov update reports two-year follow-up results from a Phase 3 study assessing long-term safety, tolerability, and efficac…
-
CLINICAL_TRIALS trial_result · 2011-11-02Clinical Trial Update: A Study to Investigate the Tolerability and Safety of Converting Stable Renal Transplant Recipients Who Receive Tacrolimus With or Without Corticosteroids From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS) [Phase 4]
Phase 4 study assessing tolerability and safety of converting stable renal transplant recipients from mycophenolate mofetil (MMF) to enteric…
-
CLINICAL_TRIALS trial_result · 2011-08-15Clinical Trial Update: Enteric-coated Mycophenolate Sodium (EC-MPS) and Mycophenolate Mofetil (MMF) in Renal Transplant Patients With Gastrointestinal (GI) Intolerance [Phase 4]
Phase 4 clinical trial evaluating enteric-coated mycophenolate sodium (EC-MPS) and mycophenolate mofetil (MMF) in renal transplant patients …
-
CLINICAL_TRIALS trial_result · 2011-06-29Clinical Trial Update: Characterization of Immunological Profile of Renal Transplant Patients Undergoing Induction Treatment With Thymoglobulin vs. IL-2 Receptor Antagonist Basiliximab
A completed trial characterizes the immunological profiles of renal transplant patients undergoing induction therapy with thymoglobulin comp…
-
CLINICAL_TRIALS trial_result · 2011-05-24Clinical Trial Update: Efficacy and Safety of Everolimus With Enteric-Coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion-free Regimen Compared to Standard Therapy in de Novo Renal Transplant Patients [Phase 4]
Phase 4 trial evaluating the efficacy and safety of everolimus with enteric-coated mycophenolate sodium in a cyclosporine-free regimen versu…
-
CLINICAL_TRIALS trial_result · 2011-05-02Clinical Trial Update: ASCERTAIN: Assessment of Everolimus in Addition to Calcineurin Inhibitor Reduction in the Maintenance of Renal Transplant Recipients [Phase 4]
Phase 4 ASCERTAIN trial evaluating adding everolimus to a reduced calcineurin inhibitor regimen in renal transplant recipients; results have…
-
CLINICAL_TRIALS trial_result · 2011-04-19Clinical Trial Update: Efficacy and Safety of Everolimus in Combination With Cyclosporine Microemulsion Versus Everolimus in Combination With Enteric-coated Mycophenolate Sodium (EC-MPS), in Adult Renal Transplant Patients in Maintenance. [Phase 3]
A Phase 3 trial in adult renal transplant patients compares everolimus with cyclosporine microemulsion versus everolimus with enteric-coated…
-
CLINICAL_TRIALS trial_result · 2011-03-11Clinical Trial Update: Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant Patients [Phase 3]
A Phase 3 trial comparing everolimus in a cyclosporine-free regimen to a low-dose cyclosporine regimen in de novo kidney transplant patients…
-
CLINICAL_TRIALS trial_result · 2011-03-11Clinical Trial Update: A Study Designed to Compare the Tolerability of an Increased Dose of Enteric-coated Mycophenolate Acid (MPA) in Renal Transplant Patients Whose Dose of Mycophenolate Mofetil (MMF) Was Reduced Due to Gastrointestinal Symptoms [Phase 4]
This Phase 4 trial compared tolerability of an increased dose of enteric-coated mycophenolate acid in renal transplant patients whose mycoph…
-
CLINICAL_TRIALS trial_result · 2011-02-02Clinical Trial Update: Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A302 [Phase 3]
A Phase 3 follow-up study evaluated the safety of enteric-coated mycophenolate sodium in renal transplant patients who completed the prior C…
-
CLINICAL_TRIALS trial_result · 2011-01-31Clinical Trial Update: Extension Study of the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients [Phase 4]
This is a Phase 4 extension study evaluating the safety and efficacy of enteric-coated mycophenolate sodium in kidney transplant recipients,…
-
CLINICAL_TRIALS trial_result · 2011-01-31Clinical Trial Update: Extension Study to Assess Tolerability and Safety of Enteric-coated Mycophenolate Sodium in Renal Transplant Recipients Who Received Mycophenolate Mofetil [Phase 4]
Phase 4 extension study evaluating tolerability and safety of enteric-coated mycophenolate sodium in renal transplant recipients who previou…
-
CLINICAL_TRIALS trial_result · 2011-01-28Clinical Trial Update: Safety and Preliminary Efficacy of the Treatment of Kidney Allografts With Curcumin-containing Preservation Solution [Phase 1]
Phase 1 study assessing the safety and preliminary efficacy of a curcumin-containing preservation solution for use in kidney allografts.